Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy and Safety Study of Telbivudine to Prevent Perinatal Transmission

This study is enrolling participants by invitation only.
Sponsor:
Information provided by:
Southeast University, China
ClinicalTrials.gov Identifier:
NCT00939068
First received: July 13, 2009
Last updated: October 13, 2009
Last verified: October 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: November 2010
  Estimated Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)